FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4296396659> ?p ?o ?g. }

• W4296396659 abstract "Background: Given the high incidence and high mortality of cervical cancer (CC) among women in developing countries, identifying reliable biomarkers for the prediction of prognosis and therapeutic response is crucial. We constructed a prognostic signature of cuproptosis-related long non-coding RNAs (lncRNAs) as a reference for individualized clinical treatment. Methods: A total of seven cuproptosis-related lncRNAs closely related to the prognosis of patients with CC were identified and used to construct a prognostic signature via least absolute shrinkage and selection operator regression analysis in the training set. The predictive performance of the signature was evaluated by Kaplan-Meier (K-M) analysis, receiver operating characteristic (ROC) analysis, and univariate and multivariate Cox analyses. Functional enrichment analysis and single-sample gene set enrichment analysis were conducted to explore the potential mechanisms of the prognostic signature, and a lncRNA-microRNA-mRNA network was created to investigate the underlying regulatory relationships between lncRNAs and cuproptosis in CC. The associations between the prognostic signature and response to immunotherapy and targeted therapy were also assessed. Finally, the prognostic value of the signature was validated using the CC tissues with clinical information in my own center. Results: A prognostic signature was developed based on seven cuproptosis-related lncRNAs, including five protective factors (AL441992.1, LINC01305, AL354833.2, CNNM3-DT, and SCAT2) and two risk factors (AL354733.3 and AC009902.2). The ROC curves confirmed the superior predictive performance of the signature compared with conventional clinicopathological characteristics in CC. The ion transport-related molecular function and various immune-related biological processes differed significantly between the two risk groups according to functional enrichment analysis. Furthermore, we discovered that individuals in the high-risk group were more likely to respond to immunotherapy and targeted therapies including trametinib and cetuximab than those in the low-risk group. Finally, CC tissues with clinical data from my own center further verify the robustness of the seven-lncRNA risk signature. Conclusion: We generated a cuproptosis-related lncRNA risk signature that could be used to predict prognosis of CC patients. Moreover, the signature could be used to predict response to immunotherapy and chemotherapy and thus could assist clinicians in making personalized treatment plans for CC patients." @default.
• W4296396659 created "2022-09-20" @default.
• W4296396659 creator A5045434872 @default.
• W4296396659 creator A5054816397 @default.
• W4296396659 creator A5057097136 @default.
• W4296396659 creator A5065377602 @default.
• W4296396659 creator A5066350349 @default.
• W4296396659 creator A5080191032 @default.
• W4296396659 date "2022-09-20" @default.
• W4296396659 modified "2023-09-26" @default.
• W4296396659 title "Signature of seven cuproptosis-related lncRNAs as a novel biomarker to predict prognosis and therapeutic response in cervical cancer" @default.
• W4296396659 cites W128654351 @default.
• W4296396659 cites W1518373859 @default.
• W4296396659 cites W1965287599 @default.
• W4296396659 cites W1965581972 @default.
• W4296396659 cites W1986440851 @default.
• W4296396659 cites W1994707797 @default.
• W4296396659 cites W2002211751 @default.
• W4296396659 cites W2011817526 @default.
• W4296396659 cites W2018663224 @default.
• W4296396659 cites W2046178144 @default.
• W4296396659 cites W2049491375 @default.
• W4296396659 cites W2097360283 @default.
• W4296396659 cites W2098287668 @default.
• W4296396659 cites W2110957978 @default.
• W4296396659 cites W2112001233 @default.
• W4296396659 cites W2112964045 @default.
• W4296396659 cites W2120405223 @default.
• W4296396659 cites W2123479813 @default.
• W4296396659 cites W2125642839 @default.
• W4296396659 cites W2140464899 @default.
• W4296396659 cites W2142442804 @default.
• W4296396659 cites W2149748804 @default.
• W4296396659 cites W2159227997 @default.
• W4296396659 cites W2174734928 @default.
• W4296396659 cites W2277468569 @default.
• W4296396659 cites W2324392028 @default.
• W4296396659 cites W2345268804 @default.
• W4296396659 cites W2557796551 @default.
• W4296396659 cites W2620663938 @default.
• W4296396659 cites W2735904407 @default.
• W4296396659 cites W2738256061 @default.
• W4296396659 cites W2790637963 @default.
• W4296396659 cites W2793350103 @default.
• W4296396659 cites W2794137041 @default.
• W4296396659 cites W2803913659 @default.
• W4296396659 cites W2891416635 @default.
• W4296396659 cites W2924678213 @default.
• W4296396659 cites W2926952933 @default.
• W4296396659 cites W2928665623 @default.
• W4296396659 cites W2937564378 @default.
• W4296396659 cites W2945294912 @default.
• W4296396659 cites W2946559903 @default.
• W4296396659 cites W2982090779 @default.
• W4296396659 cites W2983746804 @default.
• W4296396659 cites W2985066250 @default.
• W4296396659 cites W2986572941 @default.
• W4296396659 cites W2993250673 @default.
• W4296396659 cites W3027389637 @default.
• W4296396659 cites W3035499280 @default.
• W4296396659 cites W3046253990 @default.
• W4296396659 cites W3048887164 @default.
• W4296396659 cites W3082257632 @default.
• W4296396659 cites W3091521297 @default.
• W4296396659 cites W3092992066 @default.
• W4296396659 cites W3093033192 @default.
• W4296396659 cites W3093710085 @default.
• W4296396659 cites W3102480648 @default.
• W4296396659 cites W3105613303 @default.
• W4296396659 cites W3107886730 @default.
• W4296396659 cites W3116700349 @default.
• W4296396659 cites W3127523348 @default.
• W4296396659 cites W3128646645 @default.
• W4296396659 cites W3133824586 @default.
• W4296396659 cites W3136113031 @default.
• W4296396659 cites W3154635757 @default.
• W4296396659 cites W3158230065 @default.
• W4296396659 cites W3160993535 @default.
• W4296396659 cites W3162300299 @default.
• W4296396659 cites W3194040044 @default.
• W4296396659 cites W3197268709 @default.
• W4296396659 cites W4214862149 @default.
• W4296396659 cites W4220757518 @default.
• W4296396659 cites W4221115671 @default.
• W4296396659 cites W4255156463 @default.
• W4296396659 cites W4288077865 @default.
• W4296396659 cites W4294541781 @default.
• W4296396659 doi "https://doi.org/10.3389/fgene.2022.989646" @default.
• W4296396659 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36204323" @default.
• W4296396659 hasPublicationYear "2022" @default.
• W4296396659 type Work @default.
• W4296396659 citedByCount "6" @default.
• W4296396659 countsByYear W42963966592022 @default.
• W4296396659 countsByYear W42963966592023 @default.
• W4296396659 crossrefType "journal-article" @default.
• W4296396659 hasAuthorship W4296396659A5045434872 @default.
• W4296396659 hasAuthorship W4296396659A5054816397 @default.
• W4296396659 hasAuthorship W4296396659A5057097136 @default.
• W4296396659 hasAuthorship W4296396659A5065377602 @default.
• W4296396659 hasAuthorship W4296396659A5066350349 @default.

• next